Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Functional movement disorders arising after successful deep brain stimulation.

Breen DP, Rohani M, Moro E, Mayberg HS, Zurowski M, Lozano AM, Fasano A.

Neurology. 2018 Apr 13. pii: 10.1212/WNL.0000000000005530. doi: 10.1212/WNL.0000000000005530. [Epub ahead of print] No abstract available.

PMID:
29653985
2.

Psychiatric associations of adult-onset focal dystonia phenotypes.

Berman BD, Junker J, Shelton E, Sillau SH, Jinnah HA, Perlmutter JS, Espay AJ, Jankovic J, Vidailhet M, Bonnet C, Ondo W, Malaty IA, Rodríguez R, McDonald WM, Marsh L, Zurowski M, Bäumer T, Brüggemann N.

J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):595-602. doi: 10.1136/jnnp-2016-315461. Epub 2017 Apr 24.

3.

Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology.

Comella CL, Fox SH, Bhatia KP, Perlmutter JS, Jinnah HA, Zurowski M, McDonald WM, Marsh L, Rosen AR, Waliczek T, Wright LJ, Galpern WR, Stebbins GT.

Mov Disord Clin Pract. 2015 Jun;2(2):135-141. Epub 2015 Apr 6.

4.

Clinimetric testing of the comprehensive cervical dystonia rating scale.

Comella CL, Perlmutter JS, Jinnah HA, Waliczek TA, Rosen AR, Galpern WR, Adler CA, Barbano RL, Factor SA, Goetz CG, Jankovic J, Reich SG, Rodriguez RL, Severt WL, Zurowski M, Fox SH, Stebbins GT.

Mov Disord. 2016 Apr;31(4):563-9. doi: 10.1002/mds.26534. Epub 2016 Mar 12.

5.

Subjective perceived outcome of subthalamic deep brain stimulation in Parkinson's disease one year after surgery.

Maier F, Lewis CJ, Horstkoetter N, Eggers C, Dembek TA, Visser-Vandewalle V, Kuhn J, Zurowski M, Moro E, Woopen C, Timmermann L.

Parkinsonism Relat Disord. 2016 Mar;24:41-7. doi: 10.1016/j.parkreldis.2016.01.019. Epub 2016 Jan 21.

PMID:
26827110
6.

Progression of neuropsychiatric and cognitive features due to exons 2 to 5 deletion in the epsilon-sarcoglycan gene: a case report.

Multani N, Moro E, Lang A, Zurowski M, Duff Canning S, Tartaglia MC.

Neurocase. 2016;22(2):215-9. doi: 10.1080/13554794.2015.1120312. Epub 2015 Dec 11.

PMID:
26652670
7.

Long-term neuropsychiatric outcomes after pallidal stimulation in primary and secondary dystonia.

Meoni S, Zurowski M, Lozano AM, Hodaie M, Poon YY, Fallis M, Voon V, Moro E.

Neurology. 2015 Aug 4;85(5):433-40. doi: 10.1212/WNL.0000000000001811. Epub 2015 Jul 8.

8.

Developments in impulse control behaviours of Parkinson's disease.

Zurowski M, O'Brien JD.

Curr Opin Neurol. 2015 Aug;28(4):387-92. doi: 10.1097/WCO.0000000000000209. Review.

PMID:
26110803
9.

Repetitive transcranial magnetic stimulation plus standardized suggestion of benefit for functional movement disorders: an open label case series.

Shah BB, Chen R, Zurowski M, Kalia LV, Gunraj C, Lang AE.

Parkinsonism Relat Disord. 2015 Apr;21(4):407-12. doi: 10.1016/j.parkreldis.2015.01.013. Epub 2015 Jan 27.

PMID:
25737204
10.

The impact of subthalamic deep brain stimulation on caregivers of Parkinson's disease patients: an exploratory study.

Lewis CJ, Maier F, Horstkötter N, Eggers C, Visser-Vandewalle V, Moro E, Zurowski M, Kuhn J, Woopen C, Timmermann L.

J Neurol. 2015 Feb;262(2):337-45. doi: 10.1007/s00415-014-7571-9. Epub 2014 Nov 9.

PMID:
25381461
11.

Subjectively perceived personality and mood changes associated with subthalamic stimulation in patients with Parkinson's disease.

Lewis CJ, Maier F, Horstkötter N, Zywczok A, Witt K, Eggers C, Meyer TD, Dembek TA, Maarouf M, Moro E, Zurowski M, Woopen C, Kuhn J, Timmermann L.

Psychol Med. 2015 Jan;45(1):73-85. doi: 10.1017/S0033291714001081. Epub 2014 May 12.

PMID:
25066623
12.

Reluctance to start medication for Parkinson's disease: a mutual misunderstanding by patients and physicians.

Mestre TA, Teodoro T, Reginold W, Graf J, Kasten M, Sale J, Zurowski M, Miyasaki J, Ferreira JJ, Marras C.

Parkinsonism Relat Disord. 2014 Jun;20(6):608-12. doi: 10.1016/j.parkreldis.2014.03.001. Epub 2014 Mar 12.

PMID:
24661467
13.

Parkinson's disease patients with subthalamic stimulation and carers judge quality of life differently.

Lewis CJ, Maier F, Eggers C, Pelzer EA, Maarouf M, Moro E, Zurowski M, Kuhn J, Woopen C, Timmermann L.

Parkinsonism Relat Disord. 2014 May;20(5):514-9. doi: 10.1016/j.parkreldis.2014.02.009. Epub 2014 Feb 20.

PMID:
24637125
14.

Hypomania and mania related to dopamine replacement therapy in Parkinson's disease.

Maier F, Merkl J, Ellereit AL, Lewis CJ, Eggers C, Pedrosa DJ, Kalbe E, Kuhn J, Meyer TD, Zurowski M, Timmermann L.

Parkinsonism Relat Disord. 2014 Apr;20(4):421-7. doi: 10.1016/j.parkreldis.2014.01.001. Epub 2014 Jan 12.

PMID:
24467817
15.

Deep Brain Stimulation and the Search for Identity.

Witt K, Kuhn J, Timmermann L, Zurowski M, Woopen C.

Neuroethics. 2013;6:499-511. Epub 2011 Feb 16.

16.

Psychiatric comorbidities in dystonia: emerging concepts.

Zurowski M, McDonald WM, Fox S, Marsh L.

Mov Disord. 2013 Jun 15;28(7):914-20. doi: 10.1002/mds.25501. Review.

17.

Patients' expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach.

Maier F, Lewis CJ, Horstkoetter N, Eggers C, Kalbe E, Maarouf M, Kuhn J, Zurowski M, Moro E, Woopen C, Timmermann L.

J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1273-81. doi: 10.1136/jnnp-2012-303670. Epub 2013 May 28.

PMID:
23715910
18.

5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders.

Mestre TA, Zurowski M, Fox SH.

Expert Opin Investig Drugs. 2013 Apr;22(4):411-21. doi: 10.1517/13543784.2013.769957. Epub 2013 Feb 15. Review.

PMID:
23409724
19.

Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

Ray NJ, Miyasaki JM, Zurowski M, Ko JH, Cho SS, Pellecchia G, Antonelli F, Houle S, Lang AE, Strafella AP.

Neurobiol Dis. 2012 Dec;48(3):519-25. doi: 10.1016/j.nbd.2012.06.021. Epub 2012 Jul 3.

20.

Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD.

van Eimeren T, Pellecchia G, Cilia R, Ballanger B, Steeves TD, Houle S, Miyasaki JM, Zurowski M, Lang AE, Strafella AP.

Neurology. 2010 Nov 9;75(19):1711-6. doi: 10.1212/WNL.0b013e3181fc27fa. Epub 2010 Oct 6.

21.

Serotonin 2A receptors and visual hallucinations in Parkinson disease.

Ballanger B, Strafella AP, van Eimeren T, Zurowski M, Rusjan PM, Houle S, Fox SH.

Arch Neurol. 2010 Apr;67(4):416-21. doi: 10.1001/archneurol.2010.35.

PMID:
20385906
22.

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.

Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, Rusjan P, Houle S, Strafella AP.

Brain. 2009 May;132(Pt 5):1376-85. doi: 10.1093/brain/awp054. Epub 2009 Apr 3.

23.

Pain characteristics of adults 65 years of age and older referred to a tertiary care pain clinic.

Mailis-Gagnon A, Nicholson K, Yegneswaran B, Zurowski M.

Pain Res Manag. 2008 Sep-Oct;13(5):389-94.

24.

The future of the DSM pain disorder category.

Mailis Gagnon A, Nicholson K, Zurowski M.

Psychosomatics. 2008 Jul-Aug;49(4):362. doi: 10.1176/appi.psy.49.4.362. No abstract available.

PMID:
18621944
25.

Characteristics and period prevalence of self-induced disorder in patients referred to a pain clinic with the diagnosis of complex regional pain syndrome.

Mailis-Gagnon A, Nicholson K, Blumberger D, Zurowski M.

Clin J Pain. 2008 Feb;24(2):176-85. doi: 10.1097/AJP.0b013e31815ca278.

PMID:
18209524
26.

Ethnocultural and sex characteristics of patients attending a tertiary care pain clinic in Toronto, Ontario.

Mailis-Gagnon A, Yegneswaran B, Nicholson K, Lakha SF, Papagapiou M, Steiman AJ, Ng D, Cohodarevic T, Umana M, Zurowski M.

Pain Res Manag. 2007 Summer;12(2):100-6.

27.

Pain characteristics and demographics of patients attending a university-affiliated pain clinic in Toronto, Ontario.

Mailis-Gagnon A, Yegneswaran B, Lakha SF, Nicholson K, Steiman AJ, Ng D, Papagapiou M, Umana M, Cohodarevic T, Zurowski M.

Pain Res Manag. 2007 Summer;12(2):93-9.

28.

Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.

Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M.

Arch Neurol. 2007 Feb;64(2):212-6.

PMID:
17296836
29.

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.

Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J.

Neurology. 2006 Oct 10;67(7):1254-7. Epub 2006 Sep 6.

PMID:
16957130
30.

Prospective prevalence of pathologic gambling and medication association in Parkinson disease.

Voon V, Hassan K, Zurowski M, Duff-Canning S, de Souza M, Fox S, Lang AE, Miyasaki J.

Neurology. 2006 Jun 13;66(11):1750-2.

PMID:
16769956
31.

Improving outcomes in depression: a focus on somatic symptoms.

McIntyre RS, Konarski JZ, Mancini DA, Zurowski M, Giacobbe P, Soczynska JK, Kennedy SH.

J Psychosom Res. 2006 Mar;60(3):279-82.

PMID:
16516660
32.

Stress, fibromyalgia, and sleep.

Zurowski M, Shapiro C.

J Psychosom Res. 2004 Nov;57(5):415-6. No abstract available.

PMID:
15581642
33.

Sympathetic denervation impairs epidermal healing in cutaneous wounds.

Kim LR, Whelpdale K, Zurowski M, Pomeranz B.

Wound Repair Regen. 1998 May-Jun;6(3):194-201.

PMID:
9776863

Supplemental Content

Loading ...
Support Center